Saleki-Gerhardt Azita's Form 4 filing
AbbVie Inc. (ABBV) · filed Aug 14, 2025
- Accession no.
- 0001415889-25-021944
- Filed
- Aug 14, 2025
- Trade date
- Aug 12, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $8.41M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Saleki-Gerhardt AzitaCIK 0001563545 | Officer (EVP, CHIEF OPERATIONS OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2025 | Common Stock, $0.01 par value | MOption exerciseAcquired | +42,370 | $54.86 | +$2,324,418.2 | 219,662 | Direct | |
| Aug 12, 2025 | Common Stock, $0.01 par value | SSaleDisposed | −42,370 | $198.42 | −$8,407,055.4 | 177,292 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2025 | Common Stock | MOption exerciseDisposed | −42,370 | $54.86 | −$2,324,418.2 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.